|
1
|
Aghagolzadeh P and Radpour R: New trends
in molecular and cellular biomarker discovery for colorectal
cancer. World J Gastroenterol. 22:5678–5693. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vinnakota K, Zhang Y, Selvanesan BC, Topi
G, Salim T, Sand-Dejmek J, Jönsson G and Sjölander A: M2-like
macrophages induce colon cancer cell invasion via matrix
metalloproteinases. J Cell Physiol. Jan 18–2017.Epub ahead of
print. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Na H, Liu X, Li X, Zhang X, Wang Y, Wang
Z, Yuan M, Zhang Y, Ren S and Zuo Y: Novel roles of DC-SIGNR in
colon cancer cell adhesion, migration, invasion, and liver
metastasis. J Hematol Oncol. 10:282017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chazin EL, Reis RR, Junior WT, Moor LF and
Vasconcelos TR: An overview on the development of new potentially
active camptothecin analogs against cancer. Mini Rev Med Chem.
14:953–962. 2014. View Article : Google Scholar
|
|
5
|
Xie X, Tang B, Zhou J, Gao Q and Zhang P:
Inhibition of the PI3K/Akt pathway increases the chemosensitivity
of gastric cancer to vincristine. Oncol Rep. 30:773–782.
2013.PubMed/NCBI
|
|
6
|
Baird RD, Tan DS and Kaye SB: Weekly
paclitaxel in the treatment of recurrent ovarian cancer. Nat Rev
Clin Oncol. 7:575–582. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pan J, Lee Y, Wang Y and You M: Honokiol
targets mitochondria to halt cancer progression and metastasis. Mol
Nutr Food Res. 60:1383–1395. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu GJ, Lin CJ, Lin YW and Chen RM: Data
analyses of honokiol-induced autophagy of human glioma cells in
vitro and in vivo. Data Brief. 9:667–672. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu CH, Chen SH, Chang YS, Liu YW, Wu JY,
Lim YP, Yu HI and Lee YR: Honokiol, a potential therapeutic agent,
induces cell cycle arrest and program cell death in vitro and in
vivo in human thyroid cancer cells. Pharmacol Res. 115:288–298.
2017. View Article : Google Scholar
|
|
10
|
Wen J, Wang X, Pei H, Xie C, Qiu N, Li S,
Wang W, Cheng X and Chen L: Anti-psoriatic effects of Honokiol
through the inhibition of NF-κB and VEGFR-2 in animal model of
K14-VEGF transgenic mouse. J Pharmacol Sci. 128:116–124. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Prasad R and Katiyar SK: Honokiol, an
active compound of magnolia plant, inhibits growth, and progression
of cancers of different organs. Adv Exp Med Biol. 928:245–265.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pan J, Lee Y, Zhang Q, Xiong D, Wan TC,
Wang Y and You M: Honokiol decreases lung cancer metastasis through
inhibition of the STAT3 signaling pathway. Cancer Prev Res (Phila).
10:133–141. 2017. View Article : Google Scholar
|
|
13
|
Leeman-Neill RJ, Cai Q, Joyce SC, Thomas
SM, Bhola NE, Neill DB, Arbiser JL and Grandis JR: Honokiol
inhibits epidermal growth factor receptor signaling and enhances
the antitumor effects of epidermal growth factor receptor
inhibitors. Clin Cancer Res. 16:2571–2579. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lai YJ, Lin CI, Wang CL and Chao JI:
Expression of survivin and p53 modulates honokiol-induced apoptosis
in colorectal cancer cells. J Cell Biochem. 115:1888–1899.
2014.PubMed/NCBI
|
|
15
|
Ponnurangam S, Mammen JM, Ramalingam S, He
Z, Zhang Y, Umar S, Subramaniam D and Anant S: Honokiol in
combination with radiation targets notch signaling to inhibit colon
cancer stem cells. Mol Cancer Ther. 11:963–972. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wynn ML, Consul N, Merajver SD and Schnell
S: Inferring the effects of honokiol on the notch signaling pathway
in SW480 colon cancer cells. Cancer Inform. 13(Suppl 5): 1–12.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hardwick JC, Van Den Brink GR, Bleuming
SA, Ballester I, Van Den Brande JM, Keller JJ, Offerhaus GJ, Van
Deventer SJ and Peppelenbosch MP: Bone morphogenetic protein 2 is
expressed by, and acts upon, mature epithelial cells in the colon.
Gastroenterology. 126:111–121. 2004. View Article : Google Scholar
|
|
18
|
Ji T, Takabayashi H, Mao M, Han X, Xue X,
Brazil JC, Eaton KA, Shah YM and Todisco A: Regulation and function
of bone morphogenetic protein signaling in colonic injury and
inflammation. Am J Physiol Gastrointest Liver Physiol. 312:G24–G33.
2017. View Article : Google Scholar
|
|
19
|
Slattery ML, Lundgreen A, Herrick JS,
Kadlubar S, Caan BJ, Potter JD and Wolff RK: Genetic variation in
bone morphogenetic protein and colon and rectal cancer. Int J
Cancer. 130:653–664. 2012. View Article : Google Scholar
|
|
20
|
Voorneveld PW, Kodach LL, Jacobs RJ, Liv
N, Zonnevylle AC, Hoogenboom JP, Biemond I, Verspaget HW, Hommes
DW, de Rooij K, et al: Loss of SMAD4 alters BMP signaling to
promote colorectal cancer cell metastasis via activation of Rho and
ROCK. Gastroenterology. 147:196–208.e13. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Voorneveld PW, Kodach LL, Jacobs RJ, van
Noesel CJ, Peppelenbosch MP, Korkmaz KS, Molendijk I, Dekker E,
Morreau H, van Pelt GW, et al: The BMP pathway either enhances or
inhibits the Wnt pathway depending on the SMAD4 and p53 status in
CRC. Br J Cancer. 112:122–130. 2015. View Article : Google Scholar :
|
|
22
|
Xue Z, Niu LY, An G, Guo YS, Lv SC and Ren
XP: Expression of recombinant BMP-7 gene increased ossification
activity in the rabbit bone mesenchymal stem cells. Eur Rev Med
Pharmacol Sci. 19:3056–3062. 2015.PubMed/NCBI
|
|
23
|
Hao Z, Yang X, Lv Y, Li S, Purbey BK and
Su H: Intracolonically administered adeno-associated virus-bone
morphogenetic protein-7 ameliorates dextran sulphate sodium-induced
acute colitis in rats. J Gene Med. 14:482–490. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ren CM, Li Y, Chen QZ, Zeng YH, Shao Y, Wu
QX, Yuan SX, Yang JQ, Yu Y, Wu K, et al: Oridonin inhibits the
proliferation of human colon cancer cells by upregulating BMP7 to
activate p38 MAPK. Oncol Rep. 35:2691–2698. 2016.PubMed/NCBI
|
|
25
|
Luo J, Deng ZL, Luo X, Tang N, Song WX,
Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, et al: A protocol
for rapid generation of recombinant adenoviruses using the AdEasy
system. Nat Protoc. 2:1236–1247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Singh T and Katiyar SK: Honokiol, a
phytochemical from Magnolia spp., inhibits breast cancer cell
migration by targeting nitric oxide and cyclooxygenase-2. Int J
Oncol. 38:769–776. 2011.PubMed/NCBI
|
|
27
|
Singh T and Katiyar SK: Honokiol inhibits
non-small cell lung cancer cell migration by targeting
PGE2-mediated activation of β-catenin signaling. PLoS
One. 8:e607492013. View Article : Google Scholar
|
|
28
|
Li HY, Ye HG, Chen CQ, Yin LH, Wu JB, He
LC and Gao SM: Honokiol induces cell cycle arrest and apoptosis via
inhibiting class I histone deacetylases in acute myeloid leukemia.
J Cell Biochem. 116:287–298. 2015. View Article : Google Scholar
|
|
29
|
Hahm ER, Karlsson AI, Bonner MY, Arbiser
JL and Singh SV: Honokiol inhibits androgen receptor activity in
prostate cancer cells. Prostate. 74:408–420. 2014. View Article : Google Scholar :
|
|
30
|
Markowitz SD and Bertagnolli MM: Molecular
origins of cancer: Molecular basis of colorectal cancer. N Engl J
Med. 361:2449–2460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mehlen P and Fearon ER: Role of the
dependence receptor DCC in colorectal cancer pathogenesis. J Clin
Oncol. 22:3420–3428. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jung B, Staudacher JJ and Beauchamp D:
Transforming growth factor β superfamily signaling in development
of colorectal cancer. Gastroenterology. 152:36–52. 2017. View Article : Google Scholar
|
|
33
|
Yamada H, Shinmura K, Yamamura Y, Kurachi
K, Nakamura T, Tsuneyoshi T, Yokota N, Maekawa M and Sugimura H:
Identification and characterization of a novel germline p53
mutation in a patient with glioblastoma and colon cancer. Int J
Cancer. 125:973–976. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Demir L, Ekinci N, Erten C, Somali I, Can
A, Dirican A, Cokmert S, Bayoglu V, Akyol M, Kucukzeybek Y, et al:
The impact of cell proliferation markers and p53 mutation status on
prognosis of non-metastatic colon cancer. J Surg Oncol.
109:665–675. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Murray SS, Brochmann Murray EJ, Wang JC
and Duarte ME: The history and histology of bone morphogenetic
protein. Histol Histopathol. 31:721–732. 2016.PubMed/NCBI
|
|
36
|
Massagué J, Seoane J and Wotton D: Smad
transcription factors. Genes Dev. 19:2783–2810. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kawabata M, Imamura T and Miyazono K:
Signal transduction by bone morphogenetic proteins. Cytokine growth
Factor Rev. 9:49–61. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Grijelmo C, Rodrigue C, Svrcek M, Bruyneel
E, Hendrix A, de Wever O and Gespach C: Proinvasive activity of
BMP-7 through SMAD4/src-independent and ERK/Rac/JNK-dependent
signaling pathways in colon cancer cells. Cell Signal.
19:1722–1732. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bertrand FE, Angus CW, Partis WJ and
Sigounas G: Developmental pathways in colon cancer: Crosstalk
between WNT, BMP, Hedgehog and Notch. Cell Cycle. 11:4344–4351.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Brosens LA, Langeveld D, van Hattem WA,
Giardiello FM and Offerhaus GJ: Juvenile polyposis syndrome. World
J Gastroenterol. 17:4839–4844. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang Y, Chen X, Qiao M, Zhang BQ, Wang N,
Zhang Z, Liao Z, Zeng L, Deng Y, Deng F, et al: Bone morphogenetic
protein 2 inhibits the proliferation and growth of human colorectal
cancer cells. Oncol Rep. 32:1013–1020. 2014.PubMed/NCBI
|
|
42
|
Loh K, Chia JA, Greco S, Cozzi SJ,
Buttenshaw RL, Bond CE, Simms LA, Pike T, Young JP, Jass JR, et al:
Bone morphogenic protein 3 inactivation is an early and frequent
event in colorectal cancer development. Genes Chromosomes Cancer.
47:449–460. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yuan SX, Wang DX, Wu QX, Ren CM, Li Y,
Chen QZ, Zeng YH, Shao Y, Yang JQ, Bai Y, et al: BMP9/p38 MAPK is
essential for the antiproliferative effect of resveratrol on human
colon cancer. Oncol Rep. 35:939–947. 2016.
|
|
44
|
Alarmo EL, Pärssinen J, Ketolainen JM,
Savinainen K, Karhu R and Kallioniemi A: BMP7 influences
proliferation, migration, and invasion of breast cancer cells.
Cancer Lett. 275:35–43. 2009. View Article : Google Scholar
|
|
45
|
Manning AM, Williams AC, Game SM and
Paraskeva C: Differential sensitivity of human colonic adenoma and
carcinoma cells to transforming growth factor beta (TGF-beta):
Conversion of an adenoma cell line to a tumorigenic phenotype is
accompanied by a reduced response to the inhibitory effects of
TGF-beta. Oncogene. 6:1471–1476. 1991.PubMed/NCBI
|
|
46
|
Beck SE, Jung BH, Fiorino A, Gomez J,
Rosario ED, Cabrera BL, Huang SC, Chow JY and Carethers JM: Bone
morphogenetic protein signaling and growth suppression in colon
cancer. Am J Physiol Gastrointest Liver Physiol. 291:G135–G145.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Balboni AL, Cherukuri P, Ung M, DeCastro
AJ, Cheng C and DiRenzo J: p53 and ΔNp63α coregulate the
transcriptional and cellular response to TGFβ and BMP signals. Mol
Cancer Res. 13:732–742. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Fukuda N, Saitoh M, Kobayashi N and
Miyazono K: Execution of BMP-4-induced apoptosis by p53-dependent
ER dysfunction in myeloma and B-cell hybridoma cells. Oncogene.
25:3509–3517. 2006. View Article : Google Scholar : PubMed/NCBI
|
